Our first line of molecular tests will focus on some of healthcare’s largest problem areas in infectious diseases where intelligent molecular testing will significantly improve on current methods and improve the overall health of patients and save healthcare costs.  Genetix iQ will soon offer NGS and AI based tests for Chronic Disease, Cancer, Pharmacogenomics, Mental Health, Pain Management and Inherited Diseases.